AAAAAA
Results: 1-25/37
Authors:
PATAT A
Citation: A. Patat, DRIVING, DRUG RESEARCH AND THE PHARMACEUTICAL-INDUSTRY, Human psychopharmacology, 13, 1998, pp. 124-132
Authors:
SCHUCK S
ALLAIN H
GANDON JM
PATAT A
MILLET V
LECOZ F
Citation: S. Schuck et al., EFFECT OF BROMAZEPAM VERSUS PLACEBO ON INHIBITION AND WAITING CAPACITY IN YOUNG-WOMEN WITH TRAITS OF ANXIETY, Fundamental and clinical pharmacology, 12(4), 1998, pp. 463-467
Authors:
DENOLLE T
SASSANO P
PATAT A
LEBRETON S
ALLAIN H
GANDON JM
Citation: T. Denolle et al., EFFECTS OF NICARDIPINE AND CLONIDINE ON COGNITIVE FUNCTIONS AND EEG IN MIDDLE-AGED AND ELDERLY HYPERTENSIVE PATIENTS, Journal of hypertension, 16, 1998, pp. 2226-2226
Authors:
PATAT A
TROY S
BURKE J
TROCHERIE S
DANJOU P
LECOZ F
ALLAIN H
GANDON JA
Citation: A. Patat et al., ABSOLUTE BIOAVAILABILITY AND ELECTROENCEPHALOGRAPHIC EFFECTS OF CONVENTIONAL AND EXTENDED-RELEASE FORMULATIONS OF VENLAFAXINE IN HEALTHY-SUBJECTS, Journal of clinical pharmacology, 38(3), 1998, pp. 256-267
Authors:
ROSENZWEIG P
PATAT A
ZIELENIUK I
CIMAROSTI I
ALLAIN H
GANDON JM
Citation: P. Rosenzweig et al., COGNITIVE PERFORMANCE IN ELDERLY SUBJECTS AFTER A SINGLE-DOSE OF BEFLOXATONE, A NEW REVERSIBLE SELECTIVE MONOAMINE-OXIDASE-A INHIBITOR, Clinical pharmacology and therapeutics, 64(2), 1998, pp. 211-222
Authors:
PATAT A
KIRKESSELI S
LEFEBVRE P
CALIC F
MONTAY G
LECOZ F
GANDON JM
Citation: A. Patat et al., RILUZOLE SINGLE-DOSE PHARMACOKINETICS IN PATIENTS WITH IMPAIRED LIVER-FUNCTION, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 64-64
Authors:
PERETTI CS
DANION JM
KAUFFMANNMULLER F
GRANGE D
PATAT A
ROSENZWEIG P
Citation: Cs. Peretti et al., EFFECTS OF HALOPERIDOL AND AMISULPRIDE ON MOTOR AND COGNITIVE SKILL LEARNING IN HEALTHY-VOLUNTEERS, Psychopharmacology, 131(4), 1997, pp. 329-338
Authors:
PATAT A
DUBRUC C
DESCHAMP C
DURRIEU G
TROCHERIE S
CIMAROSTI I
ALLAIN H
ROSENZWEIG P
GANDON JM
Citation: A. Patat et al., EEG, MAO-A INHIBITION, PHARMACOKINETICS AND SAFETY OF BEFLOXATONE IN THE ELDERLY, Human psychopharmacology, 12(6), 1997, pp. 557-571
Authors:
PATAT A
TROCHERIE S
LECOZ F
TROY S
BURKE J
DANJOU P
ALLAIN H
GANDON JM
Citation: A. Patat et al., ABSOLUTE BIOAVAILABILITY AND EEG EFFECTS OF CT AND ER VENLAFAXINE FORMULATION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 62-62
Authors:
DENOLLE T
ALBERINI H
TURBIN A
CIMAROSTI I
PATAT A
GANDON JM
Citation: T. Denolle et al., DEFINITION OF BASE-LINE BLOOD-PRESSURE IN NORMOTENSIVE VOLUNTEERS, Archives des maladies du coeur et des vaisseaux, 90(8), 1997, pp. 1097-1101
Authors:
PATAT A
CERCLE M
TROCHERIE S
PEYTAVIN G
POTIN C
ALLAIN H
GANDON JM
Citation: A. Patat et al., LACK OF AMPHETAMINE-LIKE EFFECTS AFTER ADMINISTRATION OF MEFENOREX INNORMAL YOUNG SUBJECTS, Human psychopharmacology, 11(4), 1996, pp. 321-335
Authors:
ALLAIN H
LIEURY A
BELLIARD S
CALDWELL M
PATAT A
GANDON JM
Citation: H. Allain et al., EFFECT OF DRUGS ON MNESTIC PERFORMANCE - A METHODOLOGICAL APPROACH, Human psychopharmacology, 11(1), 1996, pp. 11-19
Authors:
LUTHRINGER R
DAGO KT
PATAT A
CAILLE P
CURET O
DURIEU G
RINAUDO G
TOUSSAINT M
GRANIER LA
MACHER JP
Citation: R. Luthringer et al., PHARMACOELECTROENCEPHALOGRAPHIC PROFILE OF BEFLOXATONE, A NEW REVERSIBLE MAO-A INHIBITOR, IN HEALTHY-SUBJECTS, Neuropsychobiology, 34(2), 1996, pp. 98-105
Authors:
RAMAEKERS JG
MUNTJEWERFF ND
UITERWIJK MMC
VANVEGGEL LMA
PATAT A
DURRIEU G
OHANLON JF
Citation: Jg. Ramaekers et al., A STUDY OF THE PHARMACODYNAMIC INTERACTION BETWEEN BEFLOXATONE AND ETHANOL ON PERFORMANCE AND MOOD IN HEALTHY-VOLUNTEERS, J PSYCHOPH, 10(4), 1996, pp. 288-294
Authors:
PATAT A
LECOZ F
DUBRUC C
GANDON JM
DURRIEU G
CIMAROSTI I
JEZEQUEL S
CURET O
ZIELENIUK I
ALLAIN H
ROSENZWEIG P
Citation: A. Patat et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF 2 DOSE REGIMENS OF BEFLOXATONE, A NEW REVERSIBLE AND SELECTIVE MONOAMINE-OXIDASE INHIBITOR, AT STEADY-STATE IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(3), 1996, pp. 216-229
Authors:
WAROT D
BERLIN I
PATAT A
DURRIEU G
ZIELENIUK I
PUECH AJ
Citation: D. Warot et al., EFFECTS OF BEFLOXATONE, A REVERSIBLE SELECTIVE MONOAMINE-OXIDASE A INHIBITOR, ON PSYCHOMOTOR FUNCTION AND MEMORY IN HEALTHY-SUBJECTS, Journal of clinical pharmacology, 36(10), 1996, pp. 942-950
Authors:
ALLAIN H
BELLIARD S
LIEURY A
MENARD G
PATAT A
LECOZ F
GANDON JM
Citation: H. Allain et al., RANDOMIZED DOUBLE-BLIND-STUDY OF MINAPRIN E VERSUS PLACEBO ON MEMORY LOSS, Therapie, 51(2), 1996, pp. 155-162
Authors:
MATTILA MJ
PATAT A
SEPPALA T
KALSKA H
JALAVA ML
VANAKOSKI J
LAVANANT C
Citation: Mj. Mattila et al., SINGLE ORAL DOSES OF AMISULPRIDE DO NOT ENHANCE THE EFFECTS OF ALCOHOL ON THE PERFORMANCE AND MEMORY OF HEALTHY-SUBJECTS, European Journal of Clinical Pharmacology, 51(2), 1996, pp. 161-166
Authors:
ABADIE P
RIOUX P
SCATTON B
ZARIFIAN E
BARRE L
PATAT A
BARON JC
Citation: P. Abadie et al., CENTRAL BENZODIAZEPINE RECEPTOR OCCUPANCY BY ZOLPIDEM IN THE HUMAN BRAIN AS ASSESSED BY POSITRON EMISSION TOMOGRAPHY, European journal of pharmacology, 295(1), 1996, pp. 35-44
Authors:
GANDON JM
LECOZ F
ENSLEN M
CHAUFFARD F
TACHON P
ALLAIN H
PATAT A
Citation: Jm. Gandon et al., DETERMINATION OF THE MAXIMAL TOLERATED DOSE OF A NEW ACUTE ORAL CAFFEINE FORMULATION IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 81-81
Authors:
ALLAIN H
PATAT A
LIEURY A
LECOZ F
JANUS C
MENARD G
GANDON JM
Citation: H. Allain et al., COMPARATIVE-STUDY OF THE EFFECTS OF ZOPICLONE (7.5 MG), ZOLPIDEM, FLUNITRAZEPAM AND A PLACEBO ON NOCTURNAL COGNITIVE PERFORMANCE IN HEALTHY-SUBJECTS, IN RELATION TO PHARMACOKINETICS, European psychiatry, 10, 1995, pp. 129-135
Authors:
PATAT A
GANDON JM
DURRIEU G
LECOZ F
CURET O
CIMAROSTI I
ALLAIN H
Citation: A. Patat et al., EFFECTS OF SINGLE AND MULTIPLE DOSES OF A NEW REVERSIBLE MAO-A INHIBITOR, BEFLOXATONE, ON PSYCHOMOTOR PERFORMANCE AND MEMORY IN HEALTHY-SUBJECTS, Human psychopharmacology, 10(2), 1995, pp. 111-125
Authors:
FAIRWEATHER DB
PATAT A
ROSENZWEIG P
CURSON VH
DUNMORE C
DUBRUC C
HINDMARCH I
Citation: Db. Fairweather et al., THE PSYCHOMOTOR AND COGNITIVE EFFECTS OF LITOXETINE IN YOUNG AND MIDDLE-AGED VOLUNTEERS, British journal of clinical pharmacology, 40(2), 1995, pp. 119-125
Authors:
PATAT A
PERAULT MC
VANDEL B
ULLIAC N
ZIELENIUK I
ROSENZWEIG P
Citation: A. Patat et al., LACK OF INTERACTION BETWEEN A NEW ANTIHISTAMINE, MIZOLASTINE, AND LORAZEPAM ON PSYCHOMOTOR PERFORMANCE AND MEMORY IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 39(1), 1995, pp. 31-38
Authors:
PATAT A
PERAULT MC
VANDEL B
DANJOU P
BROHIER S
ZIELENIUK I
ROSENZWEIG P
Citation: A. Patat et al., ASSESSMENT OF THE INTERACTION BETWEEN A PARTIAL AGONIST AND A FULL AGONIST OF BENZODIAZEPINE RECEPTORS, BASED ON PSYCHOMOTOR PERFORMANCE AND MEMORY, IN HEALTHY-VOLUNTEERS, J PSYCHOPH, 9(2), 1995, pp. 91-101